Skip to content

Comparative randomized Clinical trial of Radiofrequency Ablation (VNUS )versus Steam Ablation for the treatment of Great Saphenous Veins

Comparative randomized Clinical trial of Radiofrequency Ablation (VNUS )versus Steam Ablation for the treatment of Great Saphenous Veins - VAST trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39248
Enrollment
260
Registered
2011-02-14
Start date
2011-06-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

varices varicose veins

Interventions

1. Radiofrequency Ablation RFA will be performed with the patient under local tumescent anesthesia in an outpatient setting. Venous access is obtained by a puncture with a 19 G needle under US guid

Sponsors

Dermatologsich Centrum Wetering
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients over 18 years old • No prior treatment of the insufficient GSV • Insufficieny of the GSV measured with ultrasound imaging, reflux > 0.5 s, and diameter of vein >5 mm. • Informed consent

Exclusion criteria

Exclusion criteria: • Acute deep or superficial vein thrombosis • Agenesis of deep vein system • Vascular malformation or syndrome • Post-thrombotic syndrome, occlusive type • Pregnancy • Immobility • Allergy to lidocaine • Arterial insufficiency • Use of coumarine anticoagulants • Mentally unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Primary outcomes 1. Obliteration of the GSV and/ or absence of reflux (>0.5 sec. of retrograde flow over >10cm) along the treated segment of the GSV. This is measured using US examination. The rates will be compared between RFA and Steam Ablation at 12 and 52 weeks. 2. Venous Clinical Severity Scoring (VCSS).

Secondary

MeasureTime frame
Secondary outcomes 1. Treatment safety: a. Major complications: deep and superficial venous thrombosis (embolic events), nerve injury, skin burns, and (sub)cutaneous infections. b. Minor complications: ecchymosis, pain and hyperpigmentation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)